BTRC and lung cancer: We, therefore, added serum to serum-starved cells and found that ectopically expressed β-TrCP1 significantly shortened the protein half-life of exogenous FBXW2 in H1299 (Fig. 2c) or H358 lung cancer cells (Supplementary Fig. 2c).